SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-19-040789
Filing Date
2019-02-14
Accepted
2019-02-14 16:07:05
Documents
1
Group Members
BOXER ASSET MANAGEMENT INC.JOE LEWIS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d654287dsc13ga.htm SC 13G/A 51971
  Complete submission text file 0001193125-19-040789.txt   53677
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81034 | Film No.: 19606158
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130 (858) 400-3112
Boxer Capital, LLC (Filed by) CIK: 0001465837 (see all company filings)

IRS No.: 203828456 | State of Incorp.: DE
Type: SC 13G/A